↓ Skip to main content

Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise

Overview of attention for article published in Arthritis Research & Therapy, January 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
1 tweeter
facebook
2 Facebook pages

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise
Published in
Arthritis Research & Therapy, January 2010
DOI 10.1186/ar2982
Pubmed ID
Authors

Salahuddin Ahmed

Abstract

Green tea's active ingredient, epigallocatechin 3-gallate (EGCG), has gained significant attention among scientists and has been one of the leading plant-derived molecules studied for its potential health benefits. In the present review I summarize the findings from some of the most significant preclinical studies with EGCG in arthritic diseases. The review also addresses the limitations of the dose, pharmacokinetics, and bioavailability of EGCG in experimental animals and findings related to the EGCG-drug interaction. Although these findings provide scientific evidence of the anti-rheumatic activity of EGCG, further preclinical studies are warranted before phase clinical trials could be initiated with confidence for patients with joint diseases.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Malaysia 1 <1%
Norway 1 <1%
Unknown 117 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 17%
Student > Ph. D. Student 19 16%
Student > Master 18 15%
Student > Bachelor 17 14%
Other 8 7%
Other 22 18%
Unknown 17 14%
Readers by discipline Count As %
Medicine and Dentistry 39 32%
Agricultural and Biological Sciences 19 16%
Pharmacology, Toxicology and Pharmaceutical Science 12 10%
Nursing and Health Professions 9 7%
Chemistry 5 4%
Other 11 9%
Unknown 26 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2022.
All research outputs
#2,571,680
of 22,590,459 outputs
Outputs from Arthritis Research & Therapy
#522
of 2,957 outputs
Outputs of similar age
#14,146
of 162,969 outputs
Outputs of similar age from Arthritis Research & Therapy
#11
of 98 outputs
Altmetric has tracked 22,590,459 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,957 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 162,969 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.